Congress President
- Fabrice André, Villejuif, France
Scientific Co-Chairs
- Yelena Janjigian, New York, United States of America
- James Larkin, London, United Kingdom
Educational Chair
- Nadia Harbeck, Munich, Germany
Scientific Track Chairs
- AI and digital health: Evangelia Christodoulou, Heidelberg, Germany
- Basic science and translational research: Nicholas McGranahan, London, United Kingdom
- Breast cancer, early stage: Seock-Ah Im, Seoul, Republic of Korea
- Breast cancer, metastatic: Sara Hurvitz, Seattle, United States of America
- CNS tumours: Anna Sophie Berghoff, Vienna, Austria
- Developmental therapeutics: Funda Meric-Bernstam, Houston, United States of America
- Gastrointestinal tumours, lower digestive: Guillem Argiles Martinez, New York, United States of America
- Gastrointestinal tumours, upper digestive: Kohei Shitara, Kashiwa, Japan
- Genitourinary tumours, prostate, penile and testis: Christopher Sweeney, Adelaide, Australia
- Genitourinary tumours, renal and urothelial: Axel Bex, London, United Kingdom
- Gynaecological cancers: Antonio González-Martín, Madrid, Spain
- Haematological malignancies: Emanuele Zucca, Bellinzona, Switzerland
- Head and neck cancer, excl. thyroid: Laura Locati, Pavia, Italy
- Investigational immunotherapy: Han Chong Toh, Singapore, Singapore
- Melanoma and other skin tumours: Sapna Patel, Aurora, United States of America
- NETs and endocrine tumours: Enrique Grande, Madrid, Spain
- Non-metastatic NSCLC and other thoracic malignancies: Anne-Marie Dingemans, Rotterdam, Netherlands
- NSCLC, metastatic: Patrick Forde, Dublin, Ireland
- Policy: Jean-Yves Blay, Lyon, France
- Prevention, early detection and intervention: Suzette Delaloge, Villejuif, France
- Sarcoma: Joanna Szkandera, Graz, Austria
- Supportive and palliative care: David Hui, Houston, United States of America
- Tumour agnostic: Christoph Benedikt Westphalen, Munich, Germany
Young Oncologists Committee Representative
- Rodrigo Sanchez Bayona, Madrid, Spain